Explore
← New search
Filters:
partial
✕
Osaka International Cancer Institute
✕
dna microarray (gene expression)
✕
clear all
1 matching publication(s)
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses.
PMID 40128415 · Breast Cancer · 2025
L1
71/100